Ambra Health Launches Next-Generation ProViewer
Diagnostic viewer is designed to give providers personalized anywhere, anytime access to medical imaging.
Ambra Health has released Ambra ProViewer, its next generation cloud-based diagnostic viewer that is designed to give providers anywhere, anytime access to images.
By pairing its U.S. Food & Drug Administration-cleared ProViewer with a cloud PACS system, this tool is designed to give providers personalized mobile access to manage diagnostic images and supplemental photos and videos. It also offers full diagnostic, read-at-home, and teleradiology capabilities.
Courtesy: Ambra Health
According to a company statement, the ProViewer offers three key features:
- Easy Deployment, High Customization: A customizable keyboard and intuitive interface allows providers to choose exactly how they want to view images. It can be either a diagnostic reader or a universal viewer.
- Advanced Toolset: Multi-planar reconstruction, surface and volume rendering, and anatomical re-ordering can help providers in various areas, including research, orthopedics, and oncology.
- All-Access: All major web browsers support ProViewer without the need for any downloads, and it works on both iOS and Android mobile devices.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
